DK2037946T3 - ANTIMICROBIAL ACTIVITIES DERIVED BY PHAGER - Google Patents

Info

Publication number

DK2037946T3

DK2037946T3 DK07794592.1T DK07794592T DK2037946T3 DK 2037946 T3 DK2037946 T3 DK 2037946T3 DK 07794592 T DK07794592 T DK 07794592T DK 2037946 T3 DK2037946 T3 DK 2037946T3

Authority

DK

Denmark

Prior art keywords

phage

protein

polypeptide

cell wall

bacterial

Prior art date

2006-05-05

Links

• Espacenet
• Global Dossier
• Discuss

• 230000000845 anti-microbial effect Effects 0.000 title description 8
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 188
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 184
• 229920001184 polypeptide Polymers 0.000 claims description 181
• 210000002421 cell wall Anatomy 0.000 claims description 153
• 238000000034 method Methods 0.000 claims description 143
• 241000894006 Bacteria Species 0.000 claims description 124
• 210000004027 cell Anatomy 0.000 claims description 121
• 230000000694 effects Effects 0.000 claims description 104
• 230000001580 bacterial effect Effects 0.000 claims description 103
• 150000007523 nucleic acids Chemical class 0.000 claims description 103
• 230000027455 binding Effects 0.000 claims description 100
• 238000009739 binding Methods 0.000 claims description 99
• 102000039446 nucleic acids Human genes 0.000 claims description 90
• 108020004707 nucleic acids Proteins 0.000 claims description 90
• 230000000844 anti-bacterial effect Effects 0.000 claims description 69
• 150000001413 amino acids Chemical class 0.000 claims description 59
• 241000191940 Staphylococcus Species 0.000 claims description 25
• 238000011282 treatment Methods 0.000 claims description 19
• 239000013604 expression vector Substances 0.000 claims description 15
• 208000035143 Bacterial infection Diseases 0.000 claims description 12
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 12
• 238000000338 in vitro Methods 0.000 claims description 12
• 230000015556 catabolic process Effects 0.000 claims description 8
• 238000006731 degradation reaction Methods 0.000 claims description 8
• 230000000249 desinfective effect Effects 0.000 claims description 3
• 238000002560 therapeutic procedure Methods 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 description 245
• 102000004169 proteins and genes Human genes 0.000 description 187
• 235000018102 proteins Nutrition 0.000 description 180
• 230000000593 degrading effect Effects 0.000 description 95
• 101000814063 Salmonella phage P22 Uncharacterized 6.6 kDa protein in eae-abc2 intergenic region Proteins 0.000 description 93
• 102000004190 Enzymes Human genes 0.000 description 61
• 108090000790 Enzymes Proteins 0.000 description 61
• 229940088598 enzyme Drugs 0.000 description 61
• 239000012634 fragment Substances 0.000 description 60
• 235000001014 amino acid Nutrition 0.000 description 57
• 239000000203 mixture Substances 0.000 description 56
• 229940024606 amino acid Drugs 0.000 description 55
• 230000002101 lytic effect Effects 0.000 description 51
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 48
• 230000003197 catalytic effect Effects 0.000 description 46
• 108010013639 Peptidoglycan Proteins 0.000 description 39
• 230000014509 gene expression Effects 0.000 description 39
• 239000000047 product Substances 0.000 description 35
• 230000006870 function Effects 0.000 description 32
• 230000002147 killing effect Effects 0.000 description 32
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 29
• 101100351191 Autographa californica nuclear polyhedrosis virus PCNA gene Proteins 0.000 description 26
• 101150050790 ORF49 gene Proteins 0.000 description 26
• 102000052544 Peptidoglycan recognition protein Human genes 0.000 description 26
• 108010009051 Peptidoglycan recognition protein Proteins 0.000 description 26
• 239000013598 vector Substances 0.000 description 26
• 108700023418 Amidases Proteins 0.000 description 24
• 108090000988 Lysostaphin Proteins 0.000 description 24
• 125000003275 alpha amino acid group Chemical group 0.000 description 24
• 102000005922 amidase Human genes 0.000 description 24
• 238000003556 assay Methods 0.000 description 24
• 238000003752 polymerase chain reaction Methods 0.000 description 24
• 208000015181 infectious disease Diseases 0.000 description 22
• 210000004899 c-terminal region Anatomy 0.000 description 21
• 238000000746 purification Methods 0.000 description 20
• 239000000758 substrate Substances 0.000 description 20
• 241001465754 Metazoa Species 0.000 description 19
• 230000000875 corresponding effect Effects 0.000 description 19
• 235000010335 lysozyme Nutrition 0.000 description 19
• 230000004927 fusion Effects 0.000 description 18
• 102000035195 Peptidases Human genes 0.000 description 17
• 108091005804 Peptidases Proteins 0.000 description 17
• 230000012010 growth Effects 0.000 description 17
• 241000894007 species Species 0.000 description 17
• 241001515965 unidentified phage Species 0.000 description 17
• 108091028043 Nucleic acid sequence Proteins 0.000 description 16
• 238000010367 cloning Methods 0.000 description 16
• 239000012528 membrane Substances 0.000 description 16
• 108020004414 DNA Proteins 0.000 description 15
• 230000008436 biogenesis Effects 0.000 description 15
• 239000002773 nucleotide Substances 0.000 description 15
• 125000003729 nucleotide group Chemical group 0.000 description 15
• 235000019833 protease Nutrition 0.000 description 15
• 238000009472 formulation Methods 0.000 description 14
• 238000010369 molecular cloning Methods 0.000 description 14
• 238000012360 testing method Methods 0.000 description 14
• 108010059378 Endopeptidases Proteins 0.000 description 13
• 102000005593 Endopeptidases Human genes 0.000 description 13
• 101710154270 Nuclear protein UL4 homolog Proteins 0.000 description 13
• 238000004422 calculation algorithm Methods 0.000 description 13
• 230000007423 decrease Effects 0.000 description 13
• KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 13
• 239000013612 plasmid Substances 0.000 description 13
• 244000286779 Hansenula anomala Species 0.000 description 12
• 230000003321 amplification Effects 0.000 description 12
• 239000000463 material Substances 0.000 description 12
• 238000003199 nucleic acid amplification method Methods 0.000 description 12
• 108091008146 restriction endonucleases Proteins 0.000 description 12
• 241000282414 Homo sapiens Species 0.000 description 11
• 239000003242 anti bacterial agent Substances 0.000 description 11
• 239000003795 chemical substances by application Substances 0.000 description 11
• 108020001507 fusion proteins Proteins 0.000 description 11
• 102000037865 fusion proteins Human genes 0.000 description 11
• 230000008569 process Effects 0.000 description 11
• 230000010076 replication Effects 0.000 description 11
• 238000006467 substitution reaction Methods 0.000 description 11
• 108020004705 Codon Proteins 0.000 description 10
• 108010090665 Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase Proteins 0.000 description 10
• 108010014251 Muramidase Proteins 0.000 description 10
• 102000016943 Muramidase Human genes 0.000 description 10
• 102100030397 N-acetylmuramoyl-L-alanine amidase Human genes 0.000 description 10
• 230000003115 biocidal effect Effects 0.000 description 10
• 238000000224 chemical solution deposition Methods 0.000 description 10
• 230000002255 enzymatic effect Effects 0.000 description 10
• 239000000499 gel Substances 0.000 description 10
• 108091033319 polynucleotide Proteins 0.000 description 10
• 102000040430 polynucleotide Human genes 0.000 description 10
• 239000002157 polynucleotide Substances 0.000 description 10
• 230000003362 replicative effect Effects 0.000 description 10
• 239000000523 sample Substances 0.000 description 10
• 230000001225 therapeutic effect Effects 0.000 description 10
• 241000588724 Escherichia coli Species 0.000 description 9
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 9
• 241000700605 Viruses Species 0.000 description 9
• 125000000539 amino acid group Chemical group 0.000 description 9
• 230000003385 bacteriostatic effect Effects 0.000 description 9
• 229960000274 lysozyme Drugs 0.000 description 9
• 239000004325 lysozyme Substances 0.000 description 9
• 238000012216 screening Methods 0.000 description 9
• 230000008685 targeting Effects 0.000 description 9
• 108010022172 Chitinases Proteins 0.000 description 8
• 208000035473 Communicable disease Diseases 0.000 description 8
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 8
• 102000000395 SH3 domains Human genes 0.000 description 8
• 108050008861 SH3 domains Proteins 0.000 description 8
• 238000003776 cleavage reaction Methods 0.000 description 8
• 150000001875 compounds Chemical class 0.000 description 8
• 239000007857 degradation product Substances 0.000 description 8
• -1 e.g. Proteins 0.000 description 8
• 210000003128 head Anatomy 0.000 description 8
• 229950006780 n-acetylglucosamine Drugs 0.000 description 8
• 230000035515 penetration Effects 0.000 description 8
• 239000008194 pharmaceutical composition Substances 0.000 description 8
• 230000007017 scission Effects 0.000 description 8
• 108010062877 Bacteriocins Proteins 0.000 description 7
• 102000012286 Chitinases Human genes 0.000 description 7
• 102000004157 Hydrolases Human genes 0.000 description 7
• 108090000604 Hydrolases Proteins 0.000 description 7
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 7
• 229940088710 antibiotic agent Drugs 0.000 description 7
• 244000052616 bacterial pathogen Species 0.000 description 7
• 230000009089 cytolysis Effects 0.000 description 7
• 230000002068 genetic effect Effects 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 230000005764 inhibitory process Effects 0.000 description 7
• 230000000813 microbial effect Effects 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 238000002703 mutagenesis Methods 0.000 description 7
• 231100000350 mutagenesis Toxicity 0.000 description 7
• 239000002245 particle Substances 0.000 description 7
• 239000000546 pharmaceutical excipient Substances 0.000 description 7
• 238000010561 standard procedure Methods 0.000 description 7
• 238000004659 sterilization and disinfection Methods 0.000 description 7
• 239000000126 substance Substances 0.000 description 7
• 108700026244 Open Reading Frames Proteins 0.000 description 6
• 108010076504 Protein Sorting Signals Proteins 0.000 description 6
• 241000589516 Pseudomonas Species 0.000 description 6
• 108010025955 Pyocins Proteins 0.000 description 6
• 241000191967 Staphylococcus aureus Species 0.000 description 6
• 241000543700 Staphylococcus virus Twort Species 0.000 description 6
• 239000000443 aerosol Substances 0.000 description 6
• 238000006243 chemical reaction Methods 0.000 description 6
• 238000012217 deletion Methods 0.000 description 6
• 230000037430 deletion Effects 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 229940066758 endopeptidases Drugs 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 230000001747 exhibiting effect Effects 0.000 description 6
• 238000001990 intravenous administration Methods 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 230000008506 pathogenesis Effects 0.000 description 6
• 108700010839 phage proteins Proteins 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 230000014616 translation Effects 0.000 description 6
• 108010055851 Acetylglucosaminidase Proteins 0.000 description 5
• 102100036495 Di-N-acetylchitobiase Human genes 0.000 description 5
• 241000192125 Firmicutes Species 0.000 description 5
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical group CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
• 101710126949 Lysin Proteins 0.000 description 5
• RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 5
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 5
• 101710097941 N-acetylmuramoyl-L-alanine amidase CwlA Proteins 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 241000724233 Staphylococcus virus 11 Species 0.000 description 5
• 206010052428 Wound Diseases 0.000 description 5
• 229960003767 alanine Drugs 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 108020001778 catalytic domains Proteins 0.000 description 5
• 239000003153 chemical reaction reagent Substances 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 238000010276 construction Methods 0.000 description 5
• 230000001186 cumulative effect Effects 0.000 description 5
• 201000010099 disease Diseases 0.000 description 5
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
• 239000002552 dosage form Substances 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 230000007613 environmental effect Effects 0.000 description 5
• 238000009396 hybridization Methods 0.000 description 5
• 230000001965 increasing effect Effects 0.000 description 5
• 230000003834 intracellular effect Effects 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 229930182817 methionine Chemical group 0.000 description 5
• 229960003085 meticillin Drugs 0.000 description 5
• 230000000096 muralytic effect Effects 0.000 description 5
• 230000008520 organization Effects 0.000 description 5
• 210000001236 prokaryotic cell Anatomy 0.000 description 5
• 230000035945 sensitivity Effects 0.000 description 5
• 235000000346 sugar Nutrition 0.000 description 5
• 230000004083 survival effect Effects 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 210000002845 virion Anatomy 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 102100034668 Alpha-lactalbumin Human genes 0.000 description 4
• 241000193830 Bacillus <bacterium> Species 0.000 description 4
• 244000063299 Bacillus subtilis Species 0.000 description 4
• 235000014469 Bacillus subtilis Nutrition 0.000 description 4
• 102000014914 Carrier Proteins Human genes 0.000 description 4
• 241001137855 Caudovirales Species 0.000 description 4
• 229920002101 Chitin Polymers 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 241000701832 Enterobacteria phage T3 Species 0.000 description 4
• 241000701959 Escherichia virus Lambda Species 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
• 108010000540 Hexosaminidases Proteins 0.000 description 4
• 102000002268 Hexosaminidases Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 241000701553 Myoviridae Species 0.000 description 4
• MNLRQHMNZILYPY-MKFCKLDKSA-N N-acetyl-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MKFCKLDKSA-N 0.000 description 4
• MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 4
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
• 241000191978 Staphylococcus simulans Species 0.000 description 4
• 241000239110 Staphylococcus virus K Species 0.000 description 4
• 108020005038 Terminator Codon Proteins 0.000 description 4
• 108700005077 Viral Genes Proteins 0.000 description 4
• 238000007792 addition Methods 0.000 description 4
• 239000004599 antimicrobial Substances 0.000 description 4
• 230000001420 bacteriolytic effect Effects 0.000 description 4
• 108091008324 binding proteins Proteins 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 210000000234 capsid Anatomy 0.000 description 4
• 230000008618 cell wall macromolecule catabolic process Effects 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 230000001332 colony forming effect Effects 0.000 description 4
• 239000013078 crystal Substances 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 239000000839 emulsion Substances 0.000 description 4
• 239000000835 fiber Substances 0.000 description 4
• 230000002538 fungal effect Effects 0.000 description 4
• YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
• 210000005256 gram-negative cell Anatomy 0.000 description 4
• 230000007062 hydrolysis Effects 0.000 description 4
• 238000006460 hydrolysis reaction Methods 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 238000003018 immunoassay Methods 0.000 description 4
• 230000000977 initiatory effect Effects 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000007834 ligase chain reaction Methods 0.000 description 4
• 229910052751 metal Inorganic materials 0.000 description 4
• 239000002184 metal Substances 0.000 description 4
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
• 210000000056 organ Anatomy 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 230000005180 public health Effects 0.000 description 4
• 230000001105 regulatory effect Effects 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 238000013207 serial dilution Methods 0.000 description 4
• 230000001954 sterilising effect Effects 0.000 description 4
• 239000013589 supplement Substances 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 230000000699 topical effect Effects 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• XJFPXLWGZWAWRQ-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(O)=O XJFPXLWGZWAWRQ-UHFFFAOYSA-N 0.000 description 3
• 102100034278 Annexin A6 Human genes 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 101000870242 Bacillus phage Nf Tail knob protein gp9 Proteins 0.000 description 3
• 108010077805 Bacterial Proteins Proteins 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
• 101710200158 DNA packaging protein Proteins 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• 101710160913 GemA protein Proteins 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 101700012268 Holin Proteins 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
• 108090000942 Lactalbumin Proteins 0.000 description 3
• 108010070158 Lactose synthase Proteins 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 108091005461 Nucleic proteins Proteins 0.000 description 3
• 241000702072 Podoviridae Species 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 241000607142 Salmonella Species 0.000 description 3
• 241000702202 Siphoviridae Species 0.000 description 3
• 108091081024 Start codon Proteins 0.000 description 3
• 241000194017 Streptococcus Species 0.000 description 3
• 102000002689 Toll-like receptor Human genes 0.000 description 3
• 108020000411 Toll-like receptor Proteins 0.000 description 3
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
• 208000027418 Wounds and injury Diseases 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 238000000137 annealing Methods 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 239000003899 bactericide agent Substances 0.000 description 3
• 230000001588 bifunctional effect Effects 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 229940098773 bovine serum albumin Drugs 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 239000008121 dextrose Substances 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• 238000007429 general method Methods 0.000 description 3
• 108090001082 glucan-binding proteins Proteins 0.000 description 3
• 125000003147 glycosyl group Chemical group 0.000 description 3
• 239000007943 implant Substances 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 210000004072 lung Anatomy 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 244000005700 microbiome Species 0.000 description 3
• 239000012071 phase Substances 0.000 description 3
• 244000144977 poultry Species 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 238000001742 protein purification Methods 0.000 description 3
• 238000003259 recombinant expression Methods 0.000 description 3
• 230000028327 secretion Effects 0.000 description 3
• 210000003491 skin Anatomy 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 239000000243 solution Substances 0.000 description 3
• 230000003068 static effect Effects 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 230000005030 transcription termination Effects 0.000 description 3
• MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 3
• 235000013311 vegetables Nutrition 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• 238000011179 visual inspection Methods 0.000 description 3
• 235000021241 α-lactalbumin Nutrition 0.000 description 3
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
• UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
• 101710088758 23kDa protein Proteins 0.000 description 2
• 102100034042 Alcohol dehydrogenase 1C Human genes 0.000 description 2
• 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 2
• 101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 2
• 102000004092 Amidohydrolases Human genes 0.000 description 2
• 108090000531 Amidohydrolases Proteins 0.000 description 2
• 241000272814 Anser sp. Species 0.000 description 2
• 241000238421 Arthropoda Species 0.000 description 2
• 241000193738 Bacillus anthracis Species 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 108010066417 CPL7 lysozyme Proteins 0.000 description 2
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
• 108010059892 Cellulase Proteins 0.000 description 2
• 101000796894 Coturnix japonica Alcohol dehydrogenase 1 Proteins 0.000 description 2
• 241000235646 Cyberlindnera jadinii Species 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 241000194033 Enterococcus Species 0.000 description 2
• 241000588722 Escherichia Species 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 102000002090 Fibronectin type III Human genes 0.000 description 2
• 108050009401 Fibronectin type III Proteins 0.000 description 2
• 230000005526 G1 to G0 transition Effects 0.000 description 2
• 108010015133 Galactose oxidase Proteins 0.000 description 2
• 108060003306 Galactosyltransferase Proteins 0.000 description 2
• 102000030902 Galactosyltransferase Human genes 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• 108010055629 Glucosyltransferases Proteins 0.000 description 2
• 102000000340 Glucosyltransferases Human genes 0.000 description 2
• 108700023372 Glycosyltransferases Proteins 0.000 description 2
• 101000780463 Homo sapiens Alcohol dehydrogenase 1C Proteins 0.000 description 2
• 101000731015 Homo sapiens Peptidoglycan recognition protein 1 Proteins 0.000 description 2
• 108010003272 Hyaluronate lyase Proteins 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
• 150000008575 L-amino acids Chemical class 0.000 description 2
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical group CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 2
• 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 108090001030 Lipoproteins Proteins 0.000 description 2
• 102000004895 Lipoproteins Human genes 0.000 description 2
• 241000310423 Listeria virus P100 Species 0.000 description 2
• 101150051655 Lyz2 gene Proteins 0.000 description 2
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
• 241000018434 Mycobacterium phage TM4 Species 0.000 description 2
• 108010006232 Neuraminidase Proteins 0.000 description 2
• 102000005348 Neuraminidase Human genes 0.000 description 2
• 102100032393 Peptidoglycan recognition protein 1 Human genes 0.000 description 2
• 241000286209 Phasianidae Species 0.000 description 2
• 241000235648 Pichia Species 0.000 description 2
• 206010035148 Plague Diseases 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 241000588769 Proteus <enterobacteria> Species 0.000 description 2
• 101710180958 Putative aminoacrylate hydrolase RutD Proteins 0.000 description 2
• 241000235070 Saccharomyces Species 0.000 description 2
• 241000191965 Staphylococcus carnosus Species 0.000 description 2
• 241000191963 Staphylococcus epidermidis Species 0.000 description 2
• 241000751182 Staphylococcus epidermidis ATCC 12228 Species 0.000 description 2
• 241000751137 Staphylococcus epidermidis RP62A Species 0.000 description 2
• 235000014962 Streptococcus cremoris Nutrition 0.000 description 2
• 229930006000 Sucrose Natural products 0.000 description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
• 101710204224 Tape measure protein Proteins 0.000 description 2
• 241000255588 Tephritidae Species 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 101710159648 Uncharacterized protein Proteins 0.000 description 2
• 241000607479 Yersinia pestis Species 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 102000004139 alpha-Amylases Human genes 0.000 description 2
• 108090000637 alpha-Amylases Proteins 0.000 description 2
• 229940024171 alpha-amylase Drugs 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000002358 autolytic effect Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
• 239000001045 blue dye Substances 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 229940106157 cellulase Drugs 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000013522 chelant Substances 0.000 description 2
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
• 238000004440 column chromatography Methods 0.000 description 2
• 238000013329 compounding Methods 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 230000003413 degradative effect Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 235000013399 edible fruits Nutrition 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 210000001508 eye Anatomy 0.000 description 2
• 238000001424 field-emission electron microscopy Methods 0.000 description 2
• 210000003495 flagella Anatomy 0.000 description 2
• 239000007850 fluorescent dye Substances 0.000 description 2
• 238000011194 good manufacturing practice Methods 0.000 description 2
• 210000005255 gram-positive cell Anatomy 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• 235000014304 histidine Nutrition 0.000 description 2
• 150000002411 histidines Chemical group 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 230000015788 innate immune response Effects 0.000 description 2
• 238000007913 intrathecal administration Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 230000002934 lysing effect Effects 0.000 description 2
• 238000007726 management method Methods 0.000 description 2
• 235000013372 meat Nutrition 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
• 229960000907 methylthioninium chloride Drugs 0.000 description 2
• 238000001823 molecular biology technique Methods 0.000 description 2
• 229940051921 muramidase Drugs 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 238000003909 pattern recognition Methods 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 229940124531 pharmaceutical excipient Drugs 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 229920002704 polyhistidine Polymers 0.000 description 2
• 238000006116 polymerization reaction Methods 0.000 description 2
• 239000003380 propellant Substances 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 108020001580 protein domains Proteins 0.000 description 2
• 230000012846 protein folding Effects 0.000 description 2
• 230000002797 proteolythic effect Effects 0.000 description 2
• 238000012205 qualitative assay Methods 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 229910001415 sodium ion Inorganic materials 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 230000009897 systematic effect Effects 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 239000008158 vegetable oil Substances 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• CHBVBQWDQGWKGS-KGYWRIBKSA-N (2r)-2-[[(1s,2s,3r,4r,5s)-4-amino-2-hydroxy-6,8-dioxabicyclo[3.2.1]octan-3-yl]oxy]propanoic acid Chemical compound O[C@H]1[C@H](O[C@H](C)C(O)=O)[C@@H](N)[C@H]2OC[C@@H]1O2 CHBVBQWDQGWKGS-KGYWRIBKSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
• VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
• LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
• MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical group OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 101150035093 AMPD gene Proteins 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 241000317507 Aeromonas virus Aeh1 Species 0.000 description 1
• CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 101710086101 Alpha-lactalbumin Proteins 0.000 description 1
• 101710148087 Amidase 2 Proteins 0.000 description 1
• 101710201712 Amino acid binding protein Proteins 0.000 description 1
• 101000895977 Amycolatopsis orientalis Exo-beta-D-glucosaminidase Proteins 0.000 description 1
• 241000272525 Anas platyrhynchos Species 0.000 description 1
• 101001044245 Arabidopsis thaliana Insulin-degrading enzyme-like 1, peroxisomal Proteins 0.000 description 1
• 101100476734 Arabidopsis thaliana SBT2.4 gene Proteins 0.000 description 1
• 108010045149 Archaeal Proteins Proteins 0.000 description 1
• 208000002109 Argyria Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241000351920 Aspergillus nidulans Species 0.000 description 1
• 241000228245 Aspergillus niger Species 0.000 description 1
• 241000589151 Azotobacter Species 0.000 description 1
• 241000099686 Azotobacter sp. Species 0.000 description 1
• 241000589149 Azotobacter vinelandii Species 0.000 description 1
• 101000588395 Bacillus subtilis (strain 168) Beta-hexosaminidase Proteins 0.000 description 1
• 108700027842 Bacteriophage lambda DNA replication complex Proteins 0.000 description 1
• 101100453077 Botryococcus braunii HDR gene Proteins 0.000 description 1
• 208000031462 Bovine Mastitis Diseases 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 241000722885 Brettanomyces Species 0.000 description 1
• 241001522017 Brettanomyces anomalus Species 0.000 description 1
• 101100280051 Brucella abortus biovar 1 (strain 9-941) eryH gene Proteins 0.000 description 1
• 238000002238 CM-cellulose chromatography Methods 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
• 102100033620 Calponin-1 Human genes 0.000 description 1
• 241000589876 Campylobacter Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 241000222173 Candida parapsilosis Species 0.000 description 1
• 241001123652 Candida versatilis Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 101000658635 Catharanthus roseus Tabersonine synthase Proteins 0.000 description 1
• 101710186744 Cell wall hydrolase CwlJ Proteins 0.000 description 1
• 241000283153 Cetacea Species 0.000 description 1
• 241001112696 Clostridia Species 0.000 description 1
• 241001112695 Clostridiales Species 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 108700010070 Codon Usage Proteins 0.000 description 1
• 208000003322 Coinfection Diseases 0.000 description 1
• 241000002096 Corynascella humicola Species 0.000 description 1
• 241001125840 Coryphaenidae Species 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 125000000030 D-alanine group Chemical group [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 102100035472 DNA polymerase iota Human genes 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 241000235035 Debaryomyces Species 0.000 description 1
• 241000235036 Debaryomyces hansenii Species 0.000 description 1
• 241001043481 Debaryomyces subglobosus Species 0.000 description 1
• 241000834205 Dendropanax globosus Species 0.000 description 1
• 241000383250 Dendropanax trifidus Species 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• 241000224495 Dictyostelium Species 0.000 description 1
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
• 108090000204 Dipeptidase 1 Proteins 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 241000255601 Drosophila melanogaster Species 0.000 description 1
• 206010013710 Drug interaction Diseases 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 102000002322 Egg Proteins Human genes 0.000 description 1
• 108010000912 Egg Proteins Proteins 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 241000588914 Enterobacter Species 0.000 description 1
• 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
• 101000925647 Enterobacteria phage T3 Endolysin Proteins 0.000 description 1
• 101000764582 Enterobacteria phage T4 Tape measure protein Proteins 0.000 description 1
• 241000701867 Enterobacteria phage T7 Species 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000588698 Erwinia Species 0.000 description 1
• 241000588699 Erwinia sp. Species 0.000 description 1
• 101000621102 Escherichia phage Mu Portal protein Proteins 0.000 description 1
• 241000488157 Escherichia sp. Species 0.000 description 1
• 108010091443 Exopeptidases Proteins 0.000 description 1
• 102000018389 Exopeptidases Human genes 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 206010016952 Food poisoning Diseases 0.000 description 1
• 208000019331 Foodborne disease Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 102400001301 Gasdermin-B, C-terminal Human genes 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108030006358 Glutathionylspermidine amidases Proteins 0.000 description 1
• 108030003376 Glutathionylspermidine synthases Proteins 0.000 description 1
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
• 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
• 102000051366 Glycosyltransferases Human genes 0.000 description 1
• VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 208000037357 HIV infectious disease Diseases 0.000 description 1
• 241000589989 Helicobacter Species 0.000 description 1
• 101000945318 Homo sapiens Calponin-1 Proteins 0.000 description 1
• 101001094672 Homo sapiens DNA polymerase iota Proteins 0.000 description 1
• 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 1
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
• 101000652736 Homo sapiens Transgelin Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 101710198693 Invasin Proteins 0.000 description 1
• 241000588754 Klebsiella sp. Species 0.000 description 1
• 241000235649 Kluyveromyces Species 0.000 description 1
• QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
• ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
• UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical group OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical group C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 description 1
• QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Chemical group CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108010049736 LD-carboxypeptidase Proteins 0.000 description 1
• 101150108034 LYZ1 gene Proteins 0.000 description 1
• 241001208406 Lactobacillus virus LP65 Species 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
• 102000018497 Leukocyte cell-derived chemotaxin 2 Human genes 0.000 description 1
• 108050007732 Leukocyte cell-derived chemotaxin 2 Proteins 0.000 description 1
• NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 1
• 102000008826 LysM domains Human genes 0.000 description 1
• 108050000721 LysM domains Proteins 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102100033468 Lysozyme C Human genes 0.000 description 1
• 108050000633 Lysozyme C Proteins 0.000 description 1
• 108050007007 Lytic murein transglycosylases Proteins 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 101710105792 Membrane-bound lytic murein transglycosylase B Proteins 0.000 description 1
• 241000579835 Merops Species 0.000 description 1
• 108010063312 Metalloproteins Proteins 0.000 description 1
• 102000010750 Metalloproteins Human genes 0.000 description 1
• 241000235048 Meyerozyma guilliermondii Species 0.000 description 1
• 108030003249 Muramoyltetrapeptide carboxypeptidases Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101600101577 Mus musculus Leukocyte cell-derived chemotaxin-2 (isoform 1) Proteins 0.000 description 1
• 101100463806 Mus musculus Pglyrp1 gene Proteins 0.000 description 1
• 101100235161 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) lerI gene Proteins 0.000 description 1
• 108010079364 N-glycylalanine Proteins 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 241000189165 Nigrospora sphaerica Species 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 101710089972 Ochratoxinase Proteins 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 241000282320 Panthera leo Species 0.000 description 1
• 241000282376 Panthera tigris Species 0.000 description 1
• 241001057811 Paracoccus <mealybug> Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108700020474 Penicillin-Binding Proteins Proteins 0.000 description 1
• 101710096178 Penicillin-insensitive murein endopeptidase Proteins 0.000 description 1
• 108010087702 Penicillinase Proteins 0.000 description 1
• 101710199567 Peptidoglycan-recognition protein LA Proteins 0.000 description 1
• 108090000279 Peptidyltransferases Proteins 0.000 description 1
• 241000235645 Pichia kudriavzevii Species 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 241000283080 Proboscidea <mammal> Species 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• 102100024028 Progonadoliberin-1 Human genes 0.000 description 1
• 241000241446 Propolis farinosa Species 0.000 description 1
• 101710118538 Protease Proteins 0.000 description 1
• 101710119794 Protein TraG Proteins 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• 241000589774 Pseudomonas sp. Species 0.000 description 1
• 102000004879 Racemases and epimerases Human genes 0.000 description 1
• 108090001066 Racemases and epimerases Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 241000589187 Rhizobium sp. Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 235000011449 Rosa Nutrition 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 241000607720 Serratia Species 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 101710202138 Soluble lytic murein transglycosylase Proteins 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 101710189490 Spore cortex-lytic enzyme Proteins 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 206010041925 Staphylococcal infections Diseases 0.000 description 1
• 241000344863 Staphylococcus aureus subsp. aureus COL Species 0.000 description 1
• 241001489412 Staphylococcus aureus subsp. aureus USA300 Species 0.000 description 1
• 241001147736 Staphylococcus capitis Species 0.000 description 1
• 241001457051 Staphylococcus phage phi11 Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 241000702051 Streptococcus phage CP-7 Species 0.000 description 1
• 101000616273 Streptococcus phage Cp-1 Lysozyme Proteins 0.000 description 1
• 241000607298 Streptococcus phage Dp-1 Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 241000187759 Streptomyces albus Species 0.000 description 1
• 241000187135 Streptomyces albus G Species 0.000 description 1
• 240000001449 Tephrosia candida Species 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 241000911206 Thelephora versatilis Species 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
• 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 108010008681 Type II Secretion Systems Proteins 0.000 description 1
• 108010069584 Type III Secretion Systems Proteins 0.000 description 1
• 108010046504 Type IV Secretion Systems Proteins 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 241000282458 Ursus sp. Species 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 108010059993 Vancomycin Proteins 0.000 description 1
• 241000607598 Vibrio Species 0.000 description 1
• 241000235015 Yarrowia lipolytica Species 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 241000235017 Zygosaccharomyces Species 0.000 description 1
• 241000235029 Zygosaccharomyces bailii Species 0.000 description 1
• 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
• 229920000392 Zymosan Polymers 0.000 description 1
• 241000222295 [Candida] zeylanoides Species 0.000 description 1
• SWPYNTWPIAZGLT-UHFFFAOYSA-N [amino(ethoxy)phosphanyl]oxyethane Chemical compound CCOP(N)OCC SWPYNTWPIAZGLT-UHFFFAOYSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
• 238000010669 acid-base reaction Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000003463 adsorbent Substances 0.000 description 1
• 239000003570 air Substances 0.000 description 1
• 108010047495 alanylglycine Proteins 0.000 description 1
• NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
• 230000001476 alcoholic effect Effects 0.000 description 1
• 101150091027 ale1 gene Proteins 0.000 description 1
• 150000001371 alpha-amino acids Chemical class 0.000 description 1
• 235000008206 alpha-amino acids Nutrition 0.000 description 1
• 102000021052 amino acid binding proteins Human genes 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
• 239000010775 animal oil Substances 0.000 description 1
• 238000011203 antimicrobial therapy Methods 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000007921 bacterial pathogenicity Effects 0.000 description 1
• 229940125717 barbiturate Drugs 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 235000015278 beef Nutrition 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229940000635 beta-alanine Drugs 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 102000006635 beta-lactamase Human genes 0.000 description 1
• 229920001222 biopolymer Polymers 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 238000010322 bone marrow transplantation Methods 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 210000004900 c-terminal fragment Anatomy 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• UHBYWPGGCSDKFX-UHFFFAOYSA-N carboxyglutamic acid Chemical compound OC(=O)C(N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-UHFFFAOYSA-N 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000008162 cell wall modification Effects 0.000 description 1
• 210000003850 cellular structure Anatomy 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 239000012459 cleaning agent Substances 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 230000009133 cooperative interaction Effects 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 244000096108 cunha Species 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 231100000517 death Toxicity 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 239000003398 denaturant Substances 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 208000002925 dental caries Diseases 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 108010042194 dextransucrase Proteins 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 230000003467 diminishing effect Effects 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 239000000428 dust Substances 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 235000014103 egg white Nutrition 0.000 description 1
• 210000000969 egg white Anatomy 0.000 description 1
• 239000003792 electrolyte Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 210000003746 feather Anatomy 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 238000012252 genetic analysis Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 230000035784 germination Effects 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000004676 glycans Chemical group 0.000 description 1
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
• 150000002333 glycines Chemical class 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
• 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
• VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000009036 growth inhibition Effects 0.000 description 1
• 239000000383 hazardous chemical Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 231100000206 health hazard Toxicity 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 229920000140 heteropolymer Polymers 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
• 230000036571 hydration Effects 0.000 description 1
• 238000006703 hydration reaction Methods 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 230000006651 lactation Effects 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 238000009593 lumbar puncture Methods 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 108010054155 lysyllysine Proteins 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 210000005075 mammary gland Anatomy 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 208000004396 mastitis Diseases 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 210000002418 meninge Anatomy 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
• LSDPWZHWYPCBBB-UHFFFAOYSA-O methylsulfide anion Chemical compound [SH2+]C LSDPWZHWYPCBBB-UHFFFAOYSA-O 0.000 description 1
• 239000011325 microbead Substances 0.000 description 1
• 108010079904 microcin Proteins 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 108091005601 modified peptides Proteins 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 108010002832 murein transglycosylase Proteins 0.000 description 1
• 210000004897 n-terminal region Anatomy 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 229940097496 nasal spray Drugs 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 239000000346 nonvolatile oil Substances 0.000 description 1
• 210000001331 nose Anatomy 0.000 description 1
• 239000012038 nucleophile Substances 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 235000014593 oils and fats Nutrition 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 229950009506 penicillinase Drugs 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• 238000001066 phage therapy Methods 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 239000002953 phosphate buffered saline Substances 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 235000015277 pork Nutrition 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 238000001814 protein method Methods 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 238000012207 quantitative assay Methods 0.000 description 1
• 238000004064 recycling Methods 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 210000000697 sensory organ Anatomy 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000002910 solid waste Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000004763 spore germination Effects 0.000 description 1
• 230000028070 sporulation Effects 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 238000011476 stem cell transplantation Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 210000002105 tongue Anatomy 0.000 description 1
• 101150080369 tpiA gene Proteins 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011426 transformation method Methods 0.000 description 1
• 230000006098 transglycosylation Effects 0.000 description 1
• 238000005918 transglycosylation reaction Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 210000001635 urinary tract Anatomy 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
• 229960003165 vancomycin Drugs 0.000 description 1
• 230000008728 vascular permeability Effects 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 230000004572 zinc-binding Effects 0.000 description 1
• OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1